Pharmabiz1h
Hyderabad’s healthcare experts welcome UNGA's decision to reduce human deaths from AMR by 10% by 2030
Hyderabad’s healthcare experts welcome UNGA's decision to reduce human deaths from AMR by 10% by 2030: Our Bureau, Mumbai Saturday, September 28, 2024, 15:15 Hrs [IST] Hyderabad ...
Pharmabiz1h
Orion Corporation’s partner Bayer submits sNDA to US FDA for oral androgen receptor inhibitor darolutamide
Orion Corporation’s partner Bayer submits sNDA to US FDA for oral androgen receptor inhibitor darolutamide: Espoo, Finland Saturday, September 28, 2024, 15:00 Hrs [IST] Finnish ...
Pharmabiz2h
BFI partners with CSIR- CDRI to advance biomedical innovation
BFI partners with CSIR- CDRI to advance biomedical innovation: Our Bureau, Mumbai Saturday, September 28, 2024, 14:45 Hrs [IST] CSIR-Central Drug Research Institute (CDRI), a prem ...
Pharmabiz2h
CK Birla Hospitals unveils ‘Every Beat Counts’ report: A first-of-its-kind insight into India’s cardiac health crisis
BM Birla Heart Hospital (BMB), part of CK Birla Hospitals, has launched a first of its kind report on India’s cardiac health – ‘Every Beat Counts’. This report not only sheds light on the cardiac ...
Pharmabiz2h
World leaders commit to decisive action on antimicrobial resistance
World leaders commit to decisive action on antimicrobial resistance: Geneva Saturday, September 28, 2024, 14:00 Hrs [IST] Global leaders have approved a political declaration at t ...
Pharmabiz3h
Corning launches rabies awareness campaign with Serum Institute and SEWA India on World Rabies Day
Corning launches rabies awareness campaign with Serum Institute and SEWA India on World Rabies Day: Our Bureau, Mumbai Saturday, September 28, 2024, 13:45 Hrs [IST] Corning Incorp ...
Pharmabiz3h
Our vision is a cancer-free future generation, where everyone has access to accurate tests and affordable treatment: Meghalaya health minister
Our Bureau, Mumbai Saturday, September 28, 2024, 13:30 Hrs [IST] ...
Pharmabiz3h
Pharma associations in TN to organise interactive meeting with regulatory officers prior to preliminary inspections
Giving full support to the endeavours being initiated by the regulatory department of Tamil Nadu in implementing the Revised Schedule M in the pharma sector, the pharmaceutical industry in the state ...
Pharmabiz3h
Omeicos Therapeutics completes enrollment in phase 2a PMD-OPTION study of OMT-28 in primary mitochondrial disease
Omeicos Therapeutics completes enrollment in phase 2a PMD-OPTION study of OMT-28 in primary mitochondrial disease: Berlin, Germany Saturday, September 28, 2024, 13:00 Hrs [IST] Om ...
Pharmabiz4h
Evotec enters technology development partnership with Novo Nordisk in cell therapy
Evotec SE, a life science company, has entered a technology development partnership with Novo Nordisk in cell therapy. Both Evotec and Novo Nordisk have significant expertise and a strategic focus to ...
Pharmabiz5h
Enterprise Therapeutics’ novel cystic fibrosis investigational therapy, ETD001 receives rare paediatric disease designation in US
Enterprise Therapeutics’ novel cystic fibrosis investigational therapy, ETD001 receives rare paediatric disease designation in US: Brighton, England Saturday, September 28, 2024 ...
Pharmabiz6h
Pharming gets UK MHRA marketing authorization for Joenja to treat activated phosphoinositide 3-kinase delta (PI3Kd) syndrome
Pharming gets UK MHRA marketing authorization for Joenja to treat activated phosphoinositide 3-kinase delta (PI3Kd) syndrome: Leiden, the Netherlands Saturday, September 28, 2024, ...